Abstract:OBJECTIVE To construct the prokaryotic expression systems of tpnl7 and tpn47 genes and tpn17-tpn47 fusion of Treponema pallidum, and to establish ELISAs based on rTpN17, rTpN47 and rTpN17-TpN47 as antigens to evaluate the sensitivity and specificity of the ELISAs for detection of serological diagnosed syphilis. METHODS tpn17 and tpn47 genes were amplified and cloned by routine molecular biological methods. PCR with linking primers was used to construct artificial fusion gene tpn17-tpn47. The prokaryotic expression systems of the genes were then constructed. SDS-PAGE was used to measure the expression of the target recombinant proteins rTpN17, rTpN47 and rTpN17-TpN47. Ni-NTA affinity chromatography was applied to extract the three recombinant proteins, while Western blot was performed to determine their immunity. Using rTpN17, rTpN47 and rTpN17-TpN47 as the coated antigens, ELISAs (rTpN17-ELISA, rTpN47-ELISA and rTpN17-TpN47- ELISA) were established to detect serum samples from 200 healthy individuals, 25 RA patients, 17 SLE patients and 419 syphilis patients. Results of the ELISAs were compared to those with TRUST and TPHA. RESULTS The sequence similarities of the cloned tpnl7 and tpn47 genes and the constructed tpn17-tpn47 fusion gene were 100%, compared with the corresponding sequences in GenBank. The expression outputs of rTpN17, rTpN47 and rTpN17-TpN47 were 37.2%, 23.3% and 29.8% of the total bacterial proteins, respectively. Each of the three purified recombinant proteins showed a single fragment in gel after electrophoresis, and could take place remarkable conjugation reactions to the positive sera from syphilis patients. The detection results of rTpN17-ELISA, rTpN47-ELISA and rTpN17-TpN47-ELISA were negative for the serum samples from healthy individuals, RA and SLE patients, while presented 84.4%, 82.3% and 98.1% positive detection rates for the serum samples from syphilis patients. The positive detection rates of rTpN17-ELISA and rTpN47-ELISA were lower than that of TPHA (P<0.01), while the positive detection rate of rTpN17-TpN47-ELISA was similar to that of TPHA (P>0.05). All the positive detection rates from ELISA tests were higher than that of TRUST (71.4%). CONCLUSION rTpN17-ELISA, rTpN47-ELISA and especially rTpN17-TpN47-ELISA established in this study were of great hope as it was rapid, simple, convenient, safe, with high sensitivity and specificity for serological screening and detection of syphilis.

Evaluation of the Nontreponemal IgM Antibodies in Syphilis Serofast Patients: A New Serologic Marker for Active Syphilis

Using circulating microbial cell-free DNA to identify persistent Treponema pallidum infection in serofast syphilis patients

Acute Monoarthritis in a Delayed Diagnosis of Syphilis Patient with Persistent Rupioid Psoriasis-Like Lesions

Serofast status in syphilis: Pathogenesis to therapeutics

Sensitive and Specific ELISA Coated by TpN15-TpN17-TpN47 Fusion Protein for Detection of Antibodies to Treponema Pallidum.

Immunohistochemistry detection of Treponema pallidum and its clinical significance

[Recombinant Expression of the Fusion Antigen Based on Treponema Pallidum TpN17 and TpN47 Epitope Peptides and Establishment and Application of the Associated ELISA].

Comparing Noninvasive Predictors of Neurosyphilis among Syphilis Patients with and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in China.

[Study on ELISAs with Rtpn17, Rtpn47 and Its Fusion Protein As Antigens in the Detection of Serum Samples from Syphilis Patients].

Performance of Treponemal Tests for the Diagnosis of Syphilis

Comparison of serological detection effects of ELISA using rTpN17 or rTpN47 of Treponema pallidum as antigen with that of TPHA and TRUST]

Is repeated retreatment necessary for HIV-negative serofast early syphilis patients?

Screening for Antibodies Against Treponema Pallidum with Chemiluminescent Microparticle Immunoassay: Analysis of Discordant Serology Results and Clinical Characterization.

Expression of recombinant TpN17 antigen and preliminary application for syphilis diagnosis

Syphilis Laboratory Guidelines: Performance Characteristics of Nontreponemal Antibody Tests

Changes of serofast status in HIV negative asymptomatic neurosyphilis patients after treatment

Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects

Performance Assessment of Treponemal and Nontreponemal Tests for the Diagnosis of Acquired Syphilis

Expression of Th1/Th2 Cytokines in Early Syphilitic Lesions and Its Relationship with the Sero-conversion of RPR Test in Patients with Syphilis

Evaluating the clinical utility of semi-quantitative luciferase immunosorbent assay using Treponema pallidum antigens in syphilis diagnosis and treatment monitoring

Serological evaluation of recombinant protein antigen Tp0608 for the diagnosis of syphilis